Next company that could be in Valeant's radar is KYTH.
Valeant took Obagi(OMPI) earlier this year, now SLTM. That would complete their acquisitions of aesthetics company to compete with Allergan: Botox mother company. In fact Allergan should be looking at KYTH as well. Right now KYTH is accumulating at $40 pps.